Paper41008599
The Emerging Role of Mitochondrial Dysfunction in Thyroid Cancer: Mediating Tumor Progression, Drug Resistance, and Reshaping of the Immune Microenvironment.
Zhang Y and 6 others. Biomolecules, 2025. Cited by 6 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The Emerging Role of Mitochondrial Dysfunction in Thyroid Cancer: Mediating Tumor Progression, Drug Resistance, and Reshaping of the Immune Microenvironment. Papers, record 41008599. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41008599
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Emerging Role of Mitochondrial Dysfunction in Thyroid Cancer: Mediating Tumor Progression, Drug Resistance, and Reshaping of the Immune Microenvironment.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Tumor Microenvironment | Major topic |
| Thyroid Neoplasms | Major topic |
| Mitochondria | Major topic |
| Drug Resistance, Neoplasm | Major topic |
| Humans | |
| Animals | |
| Disease Progression |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| No. Ldyyyn2021-120; No. Ldyyyn2020-98; No. Ldyyyn2021-30 | Yong-xun Zhao | PubMed | ||
| No. 17JR5RA272; No. 22JR5RA923 | Yong-xun Zhao | PubMed |
Source PubMed
References199
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28575805 | Niclosamide induces apoptosis through mitochondrial intrinsic pathway and inhibits migration and invasion in human thyroid cancer in vitro. | Biomed Pharmacother | 2017 | https://conductscience.org/library/papers/28575805 | PubMed |
| 2 | 39581298 | The toxicological role of Myricetin in the progression of human anaplastic thyroid cancer SW1736 cell line. | Food Chem Toxicol | 2025 | https://conductscience.org/library/papers/39581298 | PubMed |
| 3 | 27597941 | Stem Cell-Derived Extracellular Vesicles and Immune-Modulation. | Front Cell Dev Biol | 2016 | https://conductscience.org/library/papers/27597941 | PubMed |
| 4 | 30366131 | Polydopamine-coated Au-Ag nanoparticle-guided photothermal colorectal cancer therapy through multiple cell death pathways. | Acta Biomater | 2019 | https://conductscience.org/library/papers/30366131 | PubMed |
| 5 | 34761353 | Mitochondrial DNA Mutagenesis: Feature of and Biomarker for Environmental Exposures and Aging. | Curr Environ Health Rep | 2021 | https://conductscience.org/library/papers/34761353 | PubMed |
| 6 | 19835928 | Thyroid cancer and inflammation. | Mol Cell Endocrinol | 2010 | https://conductscience.org/library/papers/19835928 | PubMed |
| 7 | 39667698 | SEMA3C promotes thyroid cancer via the Wnt/β-catenin pathway. | Exp Cell Res | 2025 | https://conductscience.org/library/papers/39667698 | PubMed |
| 8 | 30118906 | Hypericin-assisted photodynamic therapy against anaplastic thyroid cancer. | Photodiagnosis Photodyn Ther | 2018 | https://conductscience.org/library/papers/30118906 | PubMed |
| 9 | 31209921 | Inhibition of mitochondrial respiration by tigecycline selectively targets thyroid carcinoma and increases chemosensitivity. | Clin Exp Pharmacol Physiol | 2019 | https://conductscience.org/library/papers/31209921 | PubMed |
| 10 | 38812059 | Mitochondrial quality control in human health and disease. | Mil Med Res | 2024 | https://conductscience.org/library/papers/38812059 | PubMed |
| 11 | 34880425 | Molecular mechanisms and consequences of mitochondrial permeability transition. | Nat Rev Mol Cell Biol | 2022 | https://conductscience.org/library/papers/34880425 | PubMed |
| 12 | 35464760 | Thyroid Cancer-Associated Mitochondrial DNA Mutation G3842A Promotes Tumorigenicity via ROS-Mediated ERK1/2 Activation. | Oxid Med Cell Longev | 2022 | https://conductscience.org/library/papers/35464760 | PubMed |
| 13 | 30049712 | Mitochondrial inner membrane permeabilisation enables mtDNA release during apoptosis. | EMBO J | 2018 | https://conductscience.org/library/papers/30049712 | PubMed |
| 14 | 26942671 | Mitochondria and Cancer. | Mol Cell | 2016 | https://conductscience.org/library/papers/26942671 | PubMed |
| 15 | 15800626 | Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. | Nature | 2005 | https://conductscience.org/library/papers/15800626 | PubMed |
| 16 | 38288744 | Recent insights into the control of mitochondrial fission. | Biochem Soc Trans | 2024 | https://conductscience.org/library/papers/38288744 | PubMed |
| 17 | 39815317 | A review of the pathogenesis of mitochondria in breast cancer and progress of targeting mitochondria for breast cancer treatment. | J Transl Med | 2025 | https://conductscience.org/library/papers/39815317 | PubMed |
| 18 | 37634662 | Curcumin induces mitophagy by promoting mitochondrial succinate dehydrogenase activity and sensitizes human papillary thyroid carcinoma BCPAP cells to radioiodine treatment. | Toxicol In Vitro | 2023 | https://conductscience.org/library/papers/37634662 | PubMed |
| 19 | 34158007 | Pyruvate carboxylase promotes thyroid cancer aggressiveness through fatty acid synthesis. | BMC Cancer | 2021 | https://conductscience.org/library/papers/34158007 | PubMed |
| 20 | 27277113 | Expression of serine/glycine metabolism-related proteins is different according to the thyroid cancer subtype. | J Transl Med | 2016 | https://conductscience.org/library/papers/27277113 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42668997 | PUM1 Promotes HCC Cell Proliferation and Inhibits Mitochondria‑mediated Apoptosis, Accompanied by Activation of the PI3K-AKT Pathway. | J Hepatocell Carcinoma | 2026 | https://conductscience.org/library/papers/42668997 | PubMed |
| 42488502 | Autophagy in thyroid cancer: stage-dependent switch, mutation-specific regulation, and therapeutic targeting. | Oncol Rev | 2026 | https://conductscience.org/library/papers/42488502 | PubMed |
| 42436980 | Mitochondrial DNA mutations drive tumor heterogeneity in papillary thyroid carcinoma. | iScience | 2026 | https://conductscience.org/library/papers/42436980 | PubMed |
| 42394690 | Exposure to multiple metallic elements and risk of thyroid tumors: insights from elemental profiling, diet, and molecular characteristics plasma levels of metallic elements. | Front Oncol | 2026 | https://conductscience.org/library/papers/42394690 | PubMed |
| 42222166 | Functionalized nanomedicines for co-targeting of multiple pathways to efficiently treat thyroid cancer: prospects and challenges. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42222166 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41008599
GET https://conductscience.org/api/papers/v1/41008599/references?page=2